Aisling Capital IV, LP - Jun 24, 2021 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)

Role
10%+ Owner
Signature
AISLING CAPITAL IV, LP, by Aisling Capital Partners IV, LP, its General Partner, by Aisling Capital Partners IV LLC, its General Partner, /s/ Andrew Schiff, Managing Member
Stock symbol
ELEV
Transactions as of
Jun 24, 2021
Transactions value $
$0
Form type
4
Date filed
6/28/2021, 06:18 PM
Next filing
Jul 1, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELEV Director Stock Option Award $0 +31.2K $0.00 31.2K Jun 24, 2021 Common Stock 31.2K $16.00 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option was granted to Steven Elms, an employee of Aisling Capital, in his capacity as a director of the Issuer. Pursuant to the policies of Aisling Capital, Mr. Elms does not have any right to any of the Issuer's securities issued as part of his service on the Board and Aisling Capital is entitled to receive all of the pecuniary interest in the securities issued. The stock option vests as of 1/36 of the total shares monthly beginning on July 24, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.